Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001888660 | SCV002152824 | uncertain significance | Hereditary pancreatitis | 2021-01-15 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C25"). This variant has not been reported in the literature in individuals with PRSS1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces asparagine with isoleucine at codon 89 of the PRSS1 protein (p.Asn89Ile). The asparagine residue is highly conserved and there is a large physicochemical difference between asparagine and isoleucine. |
Ambry Genetics | RCV001888660 | SCV002743860 | uncertain significance | Hereditary pancreatitis | 2022-07-19 | criteria provided, single submitter | clinical testing | The p.N89I variant (also known as c.266A>T), located in coding exon 3 of the PRSS1 gene, results from an A to T substitution at nucleotide position 266. The asparagine at codon 89 is replaced by isoleucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |